| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.05 | 0.5 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.5 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.18 | 0.5 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |